<?xml version="1.0" encoding="UTF-8"?>
<SubmissionLabel drug="ALCAINE">
  <Text>
    <Section id="S1" name="adverse reactions">    ADVERSE REACTIONS:

  Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and, sometimes, iritis with descemetitis has been reported.



 Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has also been reported.
</Section>
    <Section id="S2" name="precautions">    PRECAUTIONS:



   



   Carcinogenesis, Mutagenesis, Impairment of Fertility.  Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenicity, or possible impairment of fertility in males or females.



    Pregnancy:



  Animal reproduction studies have not been conducted with ALCAINE  (r)  (proparacaine hydrochloride ophthalmic solution, USP) 0.5%. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.
</Section>
    <Section id="S3" name="warnings">    WARNINGS:



  NOT FOR INJECTION - FOR TOPICAL OPHTHALMIC USE ONLY. Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss.
</Section>
  </Text>
  <IgnoredRegions>
    <IgnoredRegion len="18" name="heading" section="S1" start="4" />
    <IgnoredRegion len="12" name="heading" section="S2" start="4" />
    <IgnoredRegion len="9" name="heading" section="S3" start="4" />
    <IgnoredRegion len="0" name="heading" section="S2" start="23" />
    <IgnoredRegion len="10" name="heading" section="S2" start="252" />
  </IgnoredRegions>
  <Mentions>
    </Mentions>
</SubmissionLabel>